nodes	percent_of_prediction	percent_of_DWPC	metapath
Cyclopentolate—BCHE—Perindopril—hypertension	0.157	0.348	CbGbCtD
Cyclopentolate—Diphenhydramine—Bepridil—hypertension	0.143	1	CrCrCtD
Cyclopentolate—BCHE—Ramipril—hypertension	0.13	0.289	CbGbCtD
Cyclopentolate—CHRM3—Nicardipine—hypertension	0.0877	0.194	CbGbCtD
Cyclopentolate—CHRM1—Nicardipine—hypertension	0.0762	0.169	CbGbCtD
Cyclopentolate—Venlafaxine—NPY1R—hypertension	0.00184	0.204	CrCbGaD
Cyclopentolate—Desvenlafaxine—SLC6A2—hypertension	0.00141	0.155	CrCbGaD
Cyclopentolate—Dexmethylphenidate—SLC6A2—hypertension	0.00072	0.0794	CrCbGaD
Cyclopentolate—Methylphenidate—SLC6A2—hypertension	0.00072	0.0794	CrCbGaD
Cyclopentolate—Venlafaxine—SLC6A2—hypertension	0.000711	0.0785	CrCbGaD
Cyclopentolate—Desvenlafaxine—SLC6A4—hypertension	0.000535	0.059	CrCbGaD
Cyclopentolate—Dexmethylphenidate—SLC6A3—hypertension	0.000366	0.0404	CrCbGaD
Cyclopentolate—Methylphenidate—SLC6A3—hypertension	0.000366	0.0404	CrCbGaD
Cyclopentolate—Pethidine—SLC6A2—hypertension	0.000364	0.0402	CrCbGaD
Cyclopentolate—Venlafaxine—SLC6A3—hypertension	0.000362	0.0399	CrCbGaD
Cyclopentolate—Dexmethylphenidate—SLC6A4—hypertension	0.000274	0.0302	CrCbGaD
Cyclopentolate—Methylphenidate—SLC6A4—hypertension	0.000274	0.0302	CrCbGaD
Cyclopentolate—Venlafaxine—SLC6A4—hypertension	0.00027	0.0299	CrCbGaD
Cyclopentolate—Pruritus—Nadolol—hypertension	0.000266	0.00106	CcSEcCtD
Cyclopentolate—Somnolence—Metoprolol—hypertension	0.000266	0.00106	CcSEcCtD
Cyclopentolate—Dry mouth—Doxazosin—hypertension	0.000265	0.00106	CcSEcCtD
Cyclopentolate—Flushing—Perindopril—hypertension	0.000265	0.00105	CcSEcCtD
Cyclopentolate—Flushing—Irbesartan—hypertension	0.000264	0.00105	CcSEcCtD
Cyclopentolate—Agitation—Olmesartan—hypertension	0.000263	0.00105	CcSEcCtD
Cyclopentolate—Dry mouth—Fosinopril—hypertension	0.000262	0.00104	CcSEcCtD
Cyclopentolate—Pruritus—Isradipine—hypertension	0.000262	0.00104	CcSEcCtD
Cyclopentolate—Flushing—Hydrochlorothiazide—hypertension	0.000262	0.00104	CcSEcCtD
Cyclopentolate—Pruritus—Guanfacine—hypertension	0.000261	0.00104	CcSEcCtD
Cyclopentolate—Tachycardia—Diltiazem—hypertension	0.000259	0.00103	CcSEcCtD
Cyclopentolate—Tachycardia—Indapamide—hypertension	0.000259	0.00103	CcSEcCtD
Cyclopentolate—Vertigo—Valsartan—hypertension	0.000259	0.00103	CcSEcCtD
Cyclopentolate—Vision blurred—Clonidine—hypertension	0.000259	0.00103	CcSEcCtD
Cyclopentolate—Dry mouth—Nifedipine—hypertension	0.000259	0.00103	CcSEcCtD
Cyclopentolate—Dry mouth—Verapamil—hypertension	0.000258	0.00102	CcSEcCtD
Cyclopentolate—Vertigo—Olmesartan—hypertension	0.000258	0.00102	CcSEcCtD
Cyclopentolate—Rash—Candesartan—hypertension	0.000257	0.00102	CcSEcCtD
Cyclopentolate—Tremor—Clonidine—hypertension	0.000257	0.00102	CcSEcCtD
Cyclopentolate—Dermatitis—Candesartan—hypertension	0.000257	0.00102	CcSEcCtD
Cyclopentolate—Pruritus—Metolazone—hypertension	0.000257	0.00102	CcSEcCtD
Cyclopentolate—Pruritus—Felodipine—hypertension	0.000257	0.00102	CcSEcCtD
Cyclopentolate—Tachycardia—Carvedilol—hypertension	0.000257	0.00102	CcSEcCtD
Cyclopentolate—Pruritus—Spironolactone—hypertension	0.000256	0.00102	CcSEcCtD
Cyclopentolate—Flushing—Betaxolol—hypertension	0.000255	0.00101	CcSEcCtD
Cyclopentolate—Tachycardia—Doxazosin—hypertension	0.000254	0.00101	CcSEcCtD
Cyclopentolate—Rash—Methyldopa—hypertension	0.000254	0.00101	CcSEcCtD
Cyclopentolate—Dermatitis—Methyldopa—hypertension	0.000254	0.00101	CcSEcCtD
Cyclopentolate—Agitation—Clonidine—hypertension	0.000252	0.001	CcSEcCtD
Cyclopentolate—Vision blurred—Enalapril—hypertension	0.000251	0.001	CcSEcCtD
Cyclopentolate—Pruritus—Esmolol—hypertension	0.000251	0.000998	CcSEcCtD
Cyclopentolate—Tachycardia—Fosinopril—hypertension	0.000251	0.000998	CcSEcCtD
Cyclopentolate—Tremor—Enalapril—hypertension	0.00025	0.000994	CcSEcCtD
Cyclopentolate—Rash—Amiloride—hypertension	0.000249	0.000991	CcSEcCtD
Cyclopentolate—Rash—Hydralazine—hypertension	0.000249	0.000991	CcSEcCtD
Cyclopentolate—Dermatitis—Amiloride—hypertension	0.000249	0.000991	CcSEcCtD
Cyclopentolate—Dermatitis—Hydralazine—hypertension	0.000249	0.000991	CcSEcCtD
Cyclopentolate—Conjunctivitis—Ramipril—hypertension	0.000248	0.000988	CcSEcCtD
Cyclopentolate—Flushing—Losartan—hypertension	0.000248	0.000988	CcSEcCtD
Cyclopentolate—Pruritus—Terazosin—hypertension	0.000248	0.000985	CcSEcCtD
Cyclopentolate—Tachycardia—Nifedipine—hypertension	0.000247	0.000985	CcSEcCtD
Cyclopentolate—Tachycardia—Verapamil—hypertension	0.000246	0.00098	CcSEcCtD
Cyclopentolate—Agitation—Trandolapril—hypertension	0.000246	0.000979	CcSEcCtD
Cyclopentolate—Rash—Pindolol—hypertension	0.000246	0.000979	CcSEcCtD
Cyclopentolate—Dermatitis—Pindolol—hypertension	0.000246	0.000978	CcSEcCtD
Cyclopentolate—Agitation—Enalapril—hypertension	0.000245	0.000975	CcSEcCtD
Cyclopentolate—Somnolence—Propranolol—hypertension	0.000244	0.000971	CcSEcCtD
Cyclopentolate—Conjunctivitis—Timolol—hypertension	0.000243	0.000966	CcSEcCtD
Cyclopentolate—Rash—Quinapril—hypertension	0.000242	0.000962	CcSEcCtD
Cyclopentolate—Dermatitis—Quinapril—hypertension	0.000242	0.000961	CcSEcCtD
Cyclopentolate—Pruritus—Acebutolol—hypertension	0.000241	0.00096	CcSEcCtD
Cyclopentolate—Vision blurred—Captopril—hypertension	0.000241	0.000959	CcSEcCtD
Cyclopentolate—Vertigo—Trandolapril—hypertension	0.000241	0.000957	CcSEcCtD
Cyclopentolate—Dry mouth—Valsartan—hypertension	0.00024	0.000954	CcSEcCtD
Cyclopentolate—Vertigo—Enalapril—hypertension	0.00024	0.000953	CcSEcCtD
Cyclopentolate—Pruritus—Labetalol—hypertension	0.000239	0.000952	CcSEcCtD
Cyclopentolate—Rash—Benazepril—hypertension	0.000238	0.000947	CcSEcCtD
Cyclopentolate—Dermatitis—Benazepril—hypertension	0.000238	0.000946	CcSEcCtD
Cyclopentolate—Rash—Nadolol—hypertension	0.000237	0.000943	CcSEcCtD
Cyclopentolate—Dermatitis—Nadolol—hypertension	0.000237	0.000942	CcSEcCtD
Cyclopentolate—Vertigo—Telmisartan—hypertension	0.000236	0.00094	CcSEcCtD
Cyclopentolate—Somnolence—Diltiazem—hypertension	0.000236	0.00094	CcSEcCtD
Cyclopentolate—Somnolence—Indapamide—hypertension	0.000236	0.00094	CcSEcCtD
Cyclopentolate—Somnolence—Carvedilol—hypertension	0.000234	0.00093	CcSEcCtD
Cyclopentolate—Rash—Isradipine—hypertension	0.000233	0.000929	CcSEcCtD
Cyclopentolate—Vision blurred—Irbesartan—hypertension	0.000233	0.000928	CcSEcCtD
Cyclopentolate—Dermatitis—Isradipine—hypertension	0.000233	0.000928	CcSEcCtD
Cyclopentolate—Tremor—Perindopril—hypertension	0.000233	0.000926	CcSEcCtD
Cyclopentolate—Rash—Guanfacine—hypertension	0.000233	0.000925	CcSEcCtD
Cyclopentolate—Dermatitis—Guanfacine—hypertension	0.000232	0.000924	CcSEcCtD
Cyclopentolate—Tremor—Irbesartan—hypertension	0.000232	0.000923	CcSEcCtD
Cyclopentolate—Pruritus—Eprosartan—hypertension	0.000232	0.000922	CcSEcCtD
Cyclopentolate—Rash—Nicardipine—hypertension	0.000232	0.000922	CcSEcCtD
Cyclopentolate—Dermatitis—Nicardipine—hypertension	0.000231	0.000921	CcSEcCtD
Cyclopentolate—Vision blurred—Hydrochlorothiazide—hypertension	0.000231	0.00092	CcSEcCtD
Cyclopentolate—Somnolence—Doxazosin—hypertension	0.000231	0.00092	CcSEcCtD
Cyclopentolate—Tremor—Hydrochlorothiazide—hypertension	0.00023	0.000915	CcSEcCtD
Cyclopentolate—Rash—Felodipine—hypertension	0.000229	0.000912	CcSEcCtD
Cyclopentolate—Rash—Metolazone—hypertension	0.000229	0.000912	CcSEcCtD
Cyclopentolate—Dermatitis—Felodipine—hypertension	0.000229	0.000911	CcSEcCtD
Cyclopentolate—Dermatitis—Metolazone—hypertension	0.000229	0.000911	CcSEcCtD
Cyclopentolate—Dry mouth—Clonidine—hypertension	0.000229	0.000909	CcSEcCtD
Cyclopentolate—Somnolence—Fosinopril—hypertension	0.000228	0.000909	CcSEcCtD
Cyclopentolate—Rash—Spironolactone—hypertension	0.000228	0.000908	CcSEcCtD
Cyclopentolate—Tachycardia—Olmesartan—hypertension	0.000228	0.000908	CcSEcCtD
Cyclopentolate—Agitation—Perindopril—hypertension	0.000228	0.000908	CcSEcCtD
Cyclopentolate—Dermatitis—Spironolactone—hypertension	0.000228	0.000908	CcSEcCtD
Cyclopentolate—Vision blurred—Furosemide—hypertension	0.000228	0.000905	CcSEcCtD
Cyclopentolate—Agitation—Irbesartan—hypertension	0.000227	0.000905	CcSEcCtD
Cyclopentolate—Agitation—Hydrochlorothiazide—hypertension	0.000226	0.000897	CcSEcCtD
Cyclopentolate—Somnolence—Nifedipine—hypertension	0.000225	0.000897	CcSEcCtD
Cyclopentolate—Vision blurred—Betaxolol—hypertension	0.000225	0.000896	CcSEcCtD
Cyclopentolate—Pruritus—Amlodipine—hypertension	0.000225	0.000895	CcSEcCtD
Cyclopentolate—Pruritus—Nisoldipine—hypertension	0.000225	0.000895	CcSEcCtD
Cyclopentolate—Somnolence—Verapamil—hypertension	0.000224	0.000893	CcSEcCtD
Cyclopentolate—Tremor—Betaxolol—hypertension	0.000224	0.000891	CcSEcCtD
Cyclopentolate—Hallucination—Timolol—hypertension	0.000223	0.000888	CcSEcCtD
Cyclopentolate—Vertigo—Perindopril—hypertension	0.000223	0.000888	CcSEcCtD
Cyclopentolate—Dry mouth—Trandolapril—hypertension	0.000223	0.000887	CcSEcCtD
Cyclopentolate—Vertigo—Irbesartan—hypertension	0.000222	0.000885	CcSEcCtD
Cyclopentolate—Dry mouth—Enalapril—hypertension	0.000222	0.000883	CcSEcCtD
Cyclopentolate—Agitation—Furosemide—hypertension	0.000222	0.000883	CcSEcCtD
Cyclopentolate—Rash—Terazosin—hypertension	0.000221	0.000878	CcSEcCtD
Cyclopentolate—Vertigo—Hydrochlorothiazide—hypertension	0.000221	0.000877	CcSEcCtD
Cyclopentolate—Dermatitis—Terazosin—hypertension	0.00022	0.000877	CcSEcCtD
Cyclopentolate—Vision blurred—Losartan—hypertension	0.00022	0.000873	CcSEcCtD
Cyclopentolate—Dry mouth—Telmisartan—hypertension	0.000219	0.000871	CcSEcCtD
Cyclopentolate—Tachycardia—Clonidine—hypertension	0.000219	0.00087	CcSEcCtD
Cyclopentolate—Tremor—Losartan—hypertension	0.000218	0.000868	CcSEcCtD
Cyclopentolate—Vertigo—Furosemide—hypertension	0.000217	0.000863	CcSEcCtD
Cyclopentolate—Rash—Acebutolol—hypertension	0.000215	0.000856	CcSEcCtD
Cyclopentolate—Dermatitis—Acebutolol—hypertension	0.000215	0.000855	CcSEcCtD
Cyclopentolate—Vertigo—Betaxolol—hypertension	0.000215	0.000854	CcSEcCtD
Cyclopentolate—Agitation—Losartan—hypertension	0.000214	0.000852	CcSEcCtD
Cyclopentolate—Tachycardia—Trandolapril—hypertension	0.000213	0.000848	CcSEcCtD
Cyclopentolate—Rash—Labetalol—hypertension	0.000213	0.000848	CcSEcCtD
Cyclopentolate—Dermatitis—Labetalol—hypertension	0.000213	0.000847	CcSEcCtD
Cyclopentolate—Dry mouth—Captopril—hypertension	0.000213	0.000847	CcSEcCtD
Cyclopentolate—Flushing—Ramipril—hypertension	0.000213	0.000847	CcSEcCtD
Cyclopentolate—Tachycardia—Enalapril—hypertension	0.000212	0.000845	CcSEcCtD
Cyclopentolate—Pruritus—Guanabenz—hypertension	0.000211	0.000841	CcSEcCtD
Cyclopentolate—Pruritus—Metoprolol—hypertension	0.000211	0.000841	CcSEcCtD
Cyclopentolate—Tachycardia—Telmisartan—hypertension	0.00021	0.000834	CcSEcCtD
Cyclopentolate—Vertigo—Losartan—hypertension	0.000209	0.000833	CcSEcCtD
Cyclopentolate—Somnolence—Valsartan—hypertension	0.000209	0.000831	CcSEcCtD
Cyclopentolate—Hallucination—Lisinopril—hypertension	0.000207	0.000824	CcSEcCtD
Cyclopentolate—Dry mouth—Perindopril—hypertension	0.000207	0.000823	CcSEcCtD
Cyclopentolate—Rash—Eprosartan—hypertension	0.000206	0.000822	CcSEcCtD
Cyclopentolate—Dermatitis—Eprosartan—hypertension	0.000206	0.000821	CcSEcCtD
Cyclopentolate—Dry mouth—Irbesartan—hypertension	0.000206	0.00082	CcSEcCtD
Cyclopentolate—Dry mouth—Hydrochlorothiazide—hypertension	0.000204	0.000813	CcSEcCtD
Cyclopentolate—Tachycardia—Captopril—hypertension	0.000204	0.000811	CcSEcCtD
Cyclopentolate—Dry mouth—Furosemide—hypertension	0.000201	0.0008	CcSEcCtD
Cyclopentolate—Rash—Amlodipine—hypertension	0.000201	0.000798	CcSEcCtD
Cyclopentolate—Rash—Nisoldipine—hypertension	0.000201	0.000798	CcSEcCtD
Cyclopentolate—Dermatitis—Nisoldipine—hypertension	0.0002	0.000797	CcSEcCtD
Cyclopentolate—Dermatitis—Amlodipine—hypertension	0.0002	0.000797	CcSEcCtD
Cyclopentolate—Somnolence—Clonidine—hypertension	0.000199	0.000792	CcSEcCtD
Cyclopentolate—Dry mouth—Betaxolol—hypertension	0.000199	0.000792	CcSEcCtD
Cyclopentolate—Orphenadrine—SLC6A2—hypertension	0.000199	0.0219	CrCbGaD
Cyclopentolate—Tachycardia—Perindopril—hypertension	0.000198	0.000787	CcSEcCtD
Cyclopentolate—Tachycardia—Irbesartan—hypertension	0.000197	0.000784	CcSEcCtD
Cyclopentolate—Tachycardia—Hydrochlorothiazide—hypertension	0.000196	0.000778	CcSEcCtD
Cyclopentolate—Somnolence—Trandolapril—hypertension	0.000194	0.000773	CcSEcCtD
Cyclopentolate—Dry mouth—Losartan—hypertension	0.000194	0.000772	CcSEcCtD
Cyclopentolate—Somnolence—Enalapril—hypertension	0.000193	0.00077	CcSEcCtD
Cyclopentolate—Flushing—Lisinopril—hypertension	0.000193	0.000768	CcSEcCtD
Cyclopentolate—Somnolence—Telmisartan—hypertension	0.000191	0.000759	CcSEcCtD
Cyclopentolate—Tachycardia—Betaxolol—hypertension	0.00019	0.000757	CcSEcCtD
Cyclopentolate—Rash—Guanabenz—hypertension	0.000188	0.00075	CcSEcCtD
Cyclopentolate—Rash—Metoprolol—hypertension	0.000188	0.00075	CcSEcCtD
Cyclopentolate—Dermatitis—Guanabenz—hypertension	0.000188	0.000749	CcSEcCtD
Cyclopentolate—Dermatitis—Metoprolol—hypertension	0.000188	0.000749	CcSEcCtD
Cyclopentolate—Pruritus—Diltiazem—hypertension	0.000188	0.000748	CcSEcCtD
Cyclopentolate—Pruritus—Indapamide—hypertension	0.000188	0.000748	CcSEcCtD
Cyclopentolate—Tremor—Ramipril—hypertension	0.000187	0.000744	CcSEcCtD
Cyclopentolate—Pruritus—Carvedilol—hypertension	0.000186	0.00074	CcSEcCtD
Cyclopentolate—Somnolence—Captopril—hypertension	0.000186	0.000738	CcSEcCtD
Cyclopentolate—Tachycardia—Losartan—hypertension	0.000186	0.000738	CcSEcCtD
Cyclopentolate—Pethidine—SLC6A3—hypertension	0.000185	0.0204	CrCbGaD
Cyclopentolate—Pruritus—Doxazosin—hypertension	0.000184	0.000732	CcSEcCtD
Cyclopentolate—Vision blurred—Timolol—hypertension	0.000184	0.000732	CcSEcCtD
Cyclopentolate—Agitation—Ramipril—hypertension	0.000184	0.00073	CcSEcCtD
Cyclopentolate—Pruritus—Fosinopril—hypertension	0.000182	0.000723	CcSEcCtD
Cyclopentolate—Pruritus—Eplerenone—hypertension	0.000181	0.000719	CcSEcCtD
Cyclopentolate—Somnolence—Perindopril—hypertension	0.00018	0.000717	CcSEcCtD
Cyclopentolate—Somnolence—Irbesartan—hypertension	0.00018	0.000714	CcSEcCtD
Cyclopentolate—Vertigo—Ramipril—hypertension	0.000179	0.000714	CcSEcCtD
Cyclopentolate—Pruritus—Nifedipine—hypertension	0.000179	0.000714	CcSEcCtD
Cyclopentolate—Pruritus—Verapamil—hypertension	0.000179	0.000711	CcSEcCtD
Cyclopentolate—Somnolence—Hydrochlorothiazide—hypertension	0.000178	0.000709	CcSEcCtD
Cyclopentolate—Vertigo—Timolol—hypertension	0.000175	0.000698	CcSEcCtD
Cyclopentolate—Somnolence—Furosemide—hypertension	0.000175	0.000697	CcSEcCtD
Cyclopentolate—Rash—Propranolol—hypertension	0.000173	0.000688	CcSEcCtD
Cyclopentolate—Convulsion—Ramipril—hypertension	0.000173	0.000688	CcSEcCtD
Cyclopentolate—Dermatitis—Propranolol—hypertension	0.000173	0.000688	CcSEcCtD
Cyclopentolate—Vision blurred—Lisinopril—hypertension	0.000171	0.000679	CcSEcCtD
Cyclopentolate—Tremor—Lisinopril—hypertension	0.00017	0.000675	CcSEcCtD
Cyclopentolate—Somnolence—Losartan—hypertension	0.000169	0.000672	CcSEcCtD
Cyclopentolate—Diphenhydramine—CYP2C18—hypertension	0.000169	0.0186	CrCbGaD
Cyclopentolate—Rash—Diltiazem—hypertension	0.000168	0.000666	CcSEcCtD
Cyclopentolate—Rash—Indapamide—hypertension	0.000168	0.000666	CcSEcCtD
Cyclopentolate—Dermatitis—Indapamide—hypertension	0.000167	0.000666	CcSEcCtD
Cyclopentolate—Dermatitis—Diltiazem—hypertension	0.000167	0.000666	CcSEcCtD
Cyclopentolate—Pruritus—Valsartan—hypertension	0.000166	0.000662	CcSEcCtD
Cyclopentolate—Dry mouth—Ramipril—hypertension	0.000166	0.000662	CcSEcCtD
Cyclopentolate—Rash—Carvedilol—hypertension	0.000166	0.00066	CcSEcCtD
Cyclopentolate—Dermatitis—Carvedilol—hypertension	0.000166	0.000659	CcSEcCtD
Cyclopentolate—Pruritus—Olmesartan—hypertension	0.000165	0.000658	CcSEcCtD
Cyclopentolate—Rash—Doxazosin—hypertension	0.000164	0.000653	CcSEcCtD
Cyclopentolate—Dermatitis—Doxazosin—hypertension	0.000164	0.000652	CcSEcCtD
Cyclopentolate—Vertigo—Lisinopril—hypertension	0.000163	0.000647	CcSEcCtD
Cyclopentolate—Dry mouth—Timolol—hypertension	0.000163	0.000647	CcSEcCtD
Cyclopentolate—Rash—Fosinopril—hypertension	0.000162	0.000645	CcSEcCtD
Cyclopentolate—Dermatitis—Fosinopril—hypertension	0.000162	0.000644	CcSEcCtD
Cyclopentolate—Rash—Eplerenone—hypertension	0.000161	0.000641	CcSEcCtD
Cyclopentolate—Dermatitis—Eplerenone—hypertension	0.000161	0.00064	CcSEcCtD
Cyclopentolate—Rash—Nifedipine—hypertension	0.00016	0.000636	CcSEcCtD
Cyclopentolate—Dermatitis—Nifedipine—hypertension	0.00016	0.000635	CcSEcCtD
Cyclopentolate—Rash—Verapamil—hypertension	0.000159	0.000633	CcSEcCtD
Cyclopentolate—Tachycardia—Ramipril—hypertension	0.000159	0.000633	CcSEcCtD
Cyclopentolate—Dermatitis—Verapamil—hypertension	0.000159	0.000633	CcSEcCtD
Cyclopentolate—Pruritus—Clonidine—hypertension	0.000159	0.000631	CcSEcCtD
Cyclopentolate—Pruritus—Trandolapril—hypertension	0.000155	0.000615	CcSEcCtD
Cyclopentolate—Pruritus—Enalapril—hypertension	0.000154	0.000613	CcSEcCtD
Cyclopentolate—Pruritus—Telmisartan—hypertension	0.000152	0.000604	CcSEcCtD
Cyclopentolate—Dry mouth—Lisinopril—hypertension	0.000151	0.0006	CcSEcCtD
Cyclopentolate—Rash—Valsartan—hypertension	0.000148	0.00059	CcSEcCtD
Cyclopentolate—Dermatitis—Valsartan—hypertension	0.000148	0.000589	CcSEcCtD
Cyclopentolate—Pruritus—Captopril—hypertension	0.000148	0.000588	CcSEcCtD
Cyclopentolate—Rash—Olmesartan—hypertension	0.000147	0.000587	CcSEcCtD
Cyclopentolate—Dermatitis—Olmesartan—hypertension	0.000147	0.000586	CcSEcCtD
Cyclopentolate—Somnolence—Ramipril—hypertension	0.000145	0.000577	CcSEcCtD
Cyclopentolate—Tachycardia—Lisinopril—hypertension	0.000144	0.000574	CcSEcCtD
Cyclopentolate—Pruritus—Perindopril—hypertension	0.000143	0.00057	CcSEcCtD
Cyclopentolate—Pruritus—Irbesartan—hypertension	0.000143	0.000569	CcSEcCtD
Cyclopentolate—Pruritus—Hydrochlorothiazide—hypertension	0.000142	0.000564	CcSEcCtD
Cyclopentolate—Somnolence—Timolol—hypertension	0.000142	0.000564	CcSEcCtD
Cyclopentolate—Rash—Clonidine—hypertension	0.000141	0.000562	CcSEcCtD
Cyclopentolate—Dermatitis—Clonidine—hypertension	0.000141	0.000561	CcSEcCtD
Cyclopentolate—Pruritus—Furosemide—hypertension	0.000139	0.000555	CcSEcCtD
Cyclopentolate—Pethidine—SLC6A4—hypertension	0.000138	0.0153	CrCbGaD
Cyclopentolate—Pruritus—Betaxolol—hypertension	0.000138	0.000549	CcSEcCtD
Cyclopentolate—Rash—Trandolapril—hypertension	0.000138	0.000548	CcSEcCtD
Cyclopentolate—Dermatitis—Trandolapril—hypertension	0.000138	0.000548	CcSEcCtD
Cyclopentolate—Rash—Enalapril—hypertension	0.000137	0.000546	CcSEcCtD
Cyclopentolate—Dermatitis—Enalapril—hypertension	0.000137	0.000545	CcSEcCtD
Cyclopentolate—Rash—Telmisartan—hypertension	0.000135	0.000538	CcSEcCtD
Cyclopentolate—Dermatitis—Telmisartan—hypertension	0.000135	0.000538	CcSEcCtD
Cyclopentolate—Pruritus—Losartan—hypertension	0.000134	0.000535	CcSEcCtD
Cyclopentolate—Rash—Captopril—hypertension	0.000132	0.000524	CcSEcCtD
Cyclopentolate—Dermatitis—Captopril—hypertension	0.000131	0.000523	CcSEcCtD
Cyclopentolate—Somnolence—Lisinopril—hypertension	0.000131	0.000523	CcSEcCtD
Cyclopentolate—Rash—Perindopril—hypertension	0.000128	0.000508	CcSEcCtD
Cyclopentolate—Dermatitis—Perindopril—hypertension	0.000128	0.000508	CcSEcCtD
Cyclopentolate—Rash—Irbesartan—hypertension	0.000127	0.000507	CcSEcCtD
Cyclopentolate—Dermatitis—Irbesartan—hypertension	0.000127	0.000506	CcSEcCtD
Cyclopentolate—Rash—Hydrochlorothiazide—hypertension	0.000126	0.000503	CcSEcCtD
Cyclopentolate—Dermatitis—Hydrochlorothiazide—hypertension	0.000126	0.000502	CcSEcCtD
Cyclopentolate—Rash—Furosemide—hypertension	0.000124	0.000494	CcSEcCtD
Cyclopentolate—Dermatitis—Furosemide—hypertension	0.000124	0.000494	CcSEcCtD
Cyclopentolate—Rash—Betaxolol—hypertension	0.000123	0.000489	CcSEcCtD
Cyclopentolate—Dermatitis—Betaxolol—hypertension	0.000123	0.000489	CcSEcCtD
Cyclopentolate—Rash—Losartan—hypertension	0.00012	0.000477	CcSEcCtD
Cyclopentolate—Dermatitis—Losartan—hypertension	0.00012	0.000476	CcSEcCtD
Cyclopentolate—Pruritus—Ramipril—hypertension	0.000115	0.000459	CcSEcCtD
Cyclopentolate—Pruritus—Timolol—hypertension	0.000113	0.000449	CcSEcCtD
Cyclopentolate—Pruritus—Lisinopril—hypertension	0.000105	0.000416	CcSEcCtD
Cyclopentolate—Rash—Ramipril—hypertension	0.000103	0.000409	CcSEcCtD
Cyclopentolate—Dermatitis—Ramipril—hypertension	0.000103	0.000409	CcSEcCtD
Cyclopentolate—Rash—Timolol—hypertension	0.0001	0.0004	CcSEcCtD
Cyclopentolate—Dermatitis—Timolol—hypertension	0.0001	0.000399	CcSEcCtD
Cyclopentolate—Rash—Lisinopril—hypertension	9.32e-05	0.000371	CcSEcCtD
Cyclopentolate—Dermatitis—Lisinopril—hypertension	9.31e-05	0.00037	CcSEcCtD
Cyclopentolate—Diphenhydramine—PTGS1—hypertension	8.25e-05	0.00911	CrCbGaD
Cyclopentolate—Pethidine—ALB—hypertension	7.28e-05	0.00804	CrCbGaD
Cyclopentolate—CHRM3—Signaling Pathways—BDKRB2—hypertension	1.44e-05	9.88e-05	CbGpPWpGaD
Cyclopentolate—CHRM1—Signaling by GPCR—F2—hypertension	1.43e-05	9.86e-05	CbGpPWpGaD
Cyclopentolate—CHRM1—Signaling by GPCR—PRKCB—hypertension	1.43e-05	9.86e-05	CbGpPWpGaD
Cyclopentolate—CHRM3—GPCR downstream signaling—POMC—hypertension	1.43e-05	9.86e-05	CbGpPWpGaD
Cyclopentolate—CHRM3—Signaling by GPCR—F2—hypertension	1.43e-05	9.83e-05	CbGpPWpGaD
Cyclopentolate—CHRM3—Signaling by GPCR—PRKCB—hypertension	1.43e-05	9.83e-05	CbGpPWpGaD
Cyclopentolate—CHRM1—Signaling Pathways—ADRBK1—hypertension	1.43e-05	9.8e-05	CbGpPWpGaD
Cyclopentolate—CHRM3—Metabolism—COMT—hypertension	1.42e-05	9.79e-05	CbGpPWpGaD
Cyclopentolate—BCHE—Metabolism—AGT—hypertension	1.42e-05	9.77e-05	CbGpPWpGaD
Cyclopentolate—CHRM3—Signaling Pathways—ADRBK1—hypertension	1.42e-05	9.76e-05	CbGpPWpGaD
Cyclopentolate—CHRM1—Signaling Pathways—CNR1—hypertension	1.41e-05	9.72e-05	CbGpPWpGaD
Cyclopentolate—CHRM3—Signaling Pathways—CNR1—hypertension	1.41e-05	9.69e-05	CbGpPWpGaD
Cyclopentolate—CHRM3—Metabolism—PPARGC1A—hypertension	1.4e-05	9.65e-05	CbGpPWpGaD
Cyclopentolate—CHRM3—Metabolism—GNB3—hypertension	1.4e-05	9.65e-05	CbGpPWpGaD
Cyclopentolate—CHRM1—Signaling Pathways—CALM2—hypertension	1.4e-05	9.62e-05	CbGpPWpGaD
Cyclopentolate—BCHE—Metabolism—CALM1—hypertension	1.4e-05	9.61e-05	CbGpPWpGaD
Cyclopentolate—CHRM3—Metabolism—HMOX1—hypertension	1.4e-05	9.61e-05	CbGpPWpGaD
Cyclopentolate—CHRM3—Signaling Pathways—CALM2—hypertension	1.4e-05	9.59e-05	CbGpPWpGaD
Cyclopentolate—BCHE—Metabolism—APOE—hypertension	1.39e-05	9.58e-05	CbGpPWpGaD
Cyclopentolate—CHRM1—GPCR downstream signaling—AKT2—hypertension	1.38e-05	9.51e-05	CbGpPWpGaD
Cyclopentolate—BCHE—Metabolism—CAV1—hypertension	1.38e-05	9.49e-05	CbGpPWpGaD
Cyclopentolate—CHRM1—Signaling Pathways—DRD2—hypertension	1.38e-05	9.49e-05	CbGpPWpGaD
Cyclopentolate—CHRM1—Signaling Pathways—HTR7—hypertension	1.38e-05	9.49e-05	CbGpPWpGaD
Cyclopentolate—CHRM3—GPCR downstream signaling—AKT2—hypertension	1.38e-05	9.48e-05	CbGpPWpGaD
Cyclopentolate—CHRM3—Metabolism—CAT—hypertension	1.38e-05	9.48e-05	CbGpPWpGaD
Cyclopentolate—BCHE—Metabolism—APOA1—hypertension	1.38e-05	9.47e-05	CbGpPWpGaD
Cyclopentolate—CHRM3—Signaling Pathways—HTR7—hypertension	1.38e-05	9.46e-05	CbGpPWpGaD
Cyclopentolate—CHRM3—Signaling Pathways—DRD2—hypertension	1.38e-05	9.46e-05	CbGpPWpGaD
Cyclopentolate—CHRM3—Metabolism—GNAS—hypertension	1.37e-05	9.4e-05	CbGpPWpGaD
Cyclopentolate—CHRM1—Signaling Pathways—GCG—hypertension	1.37e-05	9.39e-05	CbGpPWpGaD
Cyclopentolate—CHRM1—Signaling Pathways—PTPN1—hypertension	1.37e-05	9.39e-05	CbGpPWpGaD
Cyclopentolate—CHRM3—Signaling Pathways—PTPN1—hypertension	1.36e-05	9.36e-05	CbGpPWpGaD
Cyclopentolate—CHRM3—Signaling Pathways—GCG—hypertension	1.36e-05	9.36e-05	CbGpPWpGaD
Cyclopentolate—CHRM1—Signaling Pathways—NOTCH2—hypertension	1.34e-05	9.21e-05	CbGpPWpGaD
Cyclopentolate—CHRM1—Signaling Pathways—KL—hypertension	1.34e-05	9.21e-05	CbGpPWpGaD
Cyclopentolate—CHRM3—Metabolism—APOB—hypertension	1.34e-05	9.2e-05	CbGpPWpGaD
Cyclopentolate—CHRM3—Signaling Pathways—KL—hypertension	1.34e-05	9.18e-05	CbGpPWpGaD
Cyclopentolate—CHRM3—Signaling Pathways—NOTCH2—hypertension	1.34e-05	9.18e-05	CbGpPWpGaD
Cyclopentolate—CHRM1—Signaling Pathways—ITGAV—hypertension	1.32e-05	9.04e-05	CbGpPWpGaD
Cyclopentolate—CHRM1—Signaling Pathways—NGFR—hypertension	1.32e-05	9.04e-05	CbGpPWpGaD
Cyclopentolate—CHRM1—Signaling Pathways—KNG1—hypertension	1.31e-05	9.01e-05	CbGpPWpGaD
Cyclopentolate—CHRM3—Signaling Pathways—ITGAV—hypertension	1.31e-05	9.01e-05	CbGpPWpGaD
Cyclopentolate—CHRM3—Signaling Pathways—NGFR—hypertension	1.31e-05	9.01e-05	CbGpPWpGaD
Cyclopentolate—CHRM3—Signaling Pathways—KNG1—hypertension	1.31e-05	8.98e-05	CbGpPWpGaD
Cyclopentolate—CHRM1—Signaling by GPCR—POMC—hypertension	1.31e-05	8.98e-05	CbGpPWpGaD
Cyclopentolate—CHRM1—Signaling Pathways—AGTR1—hypertension	1.3e-05	8.96e-05	CbGpPWpGaD
Cyclopentolate—CHRM1—Signaling Pathways—PRL—hypertension	1.3e-05	8.96e-05	CbGpPWpGaD
Cyclopentolate—CHRM3—Signaling by GPCR—POMC—hypertension	1.3e-05	8.95e-05	CbGpPWpGaD
Cyclopentolate—CHRM3—Metabolism—GSTM1—hypertension	1.3e-05	8.95e-05	CbGpPWpGaD
Cyclopentolate—CHRM3—Signaling Pathways—AGTR1—hypertension	1.3e-05	8.93e-05	CbGpPWpGaD
Cyclopentolate—CHRM3—Signaling Pathways—PRL—hypertension	1.3e-05	8.93e-05	CbGpPWpGaD
Cyclopentolate—CHRM1—Signaling Pathways—STK11—hypertension	1.28e-05	8.83e-05	CbGpPWpGaD
Cyclopentolate—CHRM1—Signaling Pathways—HDAC1—hypertension	1.28e-05	8.83e-05	CbGpPWpGaD
Cyclopentolate—CHRM3—Signaling Pathways—HDAC1—hypertension	1.28e-05	8.8e-05	CbGpPWpGaD
Cyclopentolate—CHRM3—Signaling Pathways—STK11—hypertension	1.28e-05	8.8e-05	CbGpPWpGaD
Cyclopentolate—CHRM1—Signaling by GPCR—CCL2—hypertension	1.28e-05	8.79e-05	CbGpPWpGaD
Cyclopentolate—CHRM3—Metabolism—LPL—hypertension	1.28e-05	8.79e-05	CbGpPWpGaD
Cyclopentolate—CHRM3—Signaling by GPCR—CCL2—hypertension	1.27e-05	8.76e-05	CbGpPWpGaD
Cyclopentolate—CHRM1—Signaling Pathways—CXCL10—hypertension	1.27e-05	8.76e-05	CbGpPWpGaD
Cyclopentolate—CHRM1—Signaling Pathways—PLG—hypertension	1.27e-05	8.73e-05	CbGpPWpGaD
Cyclopentolate—CHRM3—Signaling Pathways—CXCL10—hypertension	1.27e-05	8.73e-05	CbGpPWpGaD
Cyclopentolate—CHRM1—GPCR downstream signaling—RHOA—hypertension	1.27e-05	8.72e-05	CbGpPWpGaD
Cyclopentolate—CHRM3—Signaling Pathways—PLG—hypertension	1.27e-05	8.7e-05	CbGpPWpGaD
Cyclopentolate—CHRM3—GPCR downstream signaling—RHOA—hypertension	1.26e-05	8.69e-05	CbGpPWpGaD
Cyclopentolate—CHRM1—Signaling by GPCR—AKT2—hypertension	1.26e-05	8.63e-05	CbGpPWpGaD
Cyclopentolate—CHRM1—GPCR downstream signaling—PIK3R1—hypertension	1.25e-05	8.63e-05	CbGpPWpGaD
Cyclopentolate—CHRM3—Signaling by GPCR—AKT2—hypertension	1.25e-05	8.61e-05	CbGpPWpGaD
Cyclopentolate—CHRM3—Metabolism—ADCY5—hypertension	1.25e-05	8.6e-05	CbGpPWpGaD
Cyclopentolate—CHRM3—GPCR downstream signaling—PIK3R1—hypertension	1.25e-05	8.6e-05	CbGpPWpGaD
Cyclopentolate—CHRM3—Metabolism—GPX1—hypertension	1.25e-05	8.57e-05	CbGpPWpGaD
Cyclopentolate—CHRM1—Signaling Pathways—ADRB2—hypertension	1.24e-05	8.5e-05	CbGpPWpGaD
Cyclopentolate—CHRM3—Metabolism—PRKCA—hypertension	1.23e-05	8.49e-05	CbGpPWpGaD
Cyclopentolate—CHRM3—Metabolism—CYP1A1—hypertension	1.23e-05	8.49e-05	CbGpPWpGaD
Cyclopentolate—CHRM3—Signaling Pathways—ADRB2—hypertension	1.23e-05	8.47e-05	CbGpPWpGaD
Cyclopentolate—CHRM1—Signaling Pathways—PRKCE—hypertension	1.22e-05	8.39e-05	CbGpPWpGaD
Cyclopentolate—CHRM3—Signaling Pathways—PRKCE—hypertension	1.22e-05	8.37e-05	CbGpPWpGaD
Cyclopentolate—CHRM3—Metabolism—CD36—hypertension	1.21e-05	8.35e-05	CbGpPWpGaD
Cyclopentolate—BCHE—Metabolism—PPARG—hypertension	1.21e-05	8.34e-05	CbGpPWpGaD
Cyclopentolate—CHRM1—Signaling Pathways—PDGFA—hypertension	1.21e-05	8.29e-05	CbGpPWpGaD
Cyclopentolate—CHRM1—Signaling Pathways—VAV3—hypertension	1.21e-05	8.29e-05	CbGpPWpGaD
Cyclopentolate—CHRM3—Signaling Pathways—PDGFA—hypertension	1.2e-05	8.26e-05	CbGpPWpGaD
Cyclopentolate—CHRM3—Signaling Pathways—VAV3—hypertension	1.2e-05	8.26e-05	CbGpPWpGaD
Cyclopentolate—BCHE—Metabolism—POMC—hypertension	1.2e-05	8.23e-05	CbGpPWpGaD
Cyclopentolate—BCHE—Metabolism—INS—hypertension	1.19e-05	8.18e-05	CbGpPWpGaD
Cyclopentolate—CHRM1—Signaling Pathways—TGFBR2—hypertension	1.19e-05	8.17e-05	CbGpPWpGaD
Cyclopentolate—CHRM3—Signaling Pathways—TGFBR2—hypertension	1.18e-05	8.14e-05	CbGpPWpGaD
Cyclopentolate—CHRM1—Signaling Pathways—GNB3—hypertension	1.18e-05	8.09e-05	CbGpPWpGaD
Cyclopentolate—CHRM3—Signaling Pathways—GNB3—hypertension	1.17e-05	8.07e-05	CbGpPWpGaD
Cyclopentolate—CHRM1—Signaling Pathways—AVP—hypertension	1.16e-05	7.99e-05	CbGpPWpGaD
Cyclopentolate—CHRM3—Signaling Pathways—AVP—hypertension	1.16e-05	7.96e-05	CbGpPWpGaD
Cyclopentolate—CHRM1—Signaling by GPCR—RHOA—hypertension	1.15e-05	7.92e-05	CbGpPWpGaD
Cyclopentolate—CHRM3—Metabolism—MTHFR—hypertension	1.15e-05	7.91e-05	CbGpPWpGaD
Cyclopentolate—CHRM3—Signaling by GPCR—RHOA—hypertension	1.15e-05	7.89e-05	CbGpPWpGaD
Cyclopentolate—CHRM1—Signaling Pathways—GNAS—hypertension	1.15e-05	7.88e-05	CbGpPWpGaD
Cyclopentolate—CHRM3—Signaling Pathways—GNAS—hypertension	1.14e-05	7.86e-05	CbGpPWpGaD
Cyclopentolate—CHRM1—Signaling by GPCR—PIK3R1—hypertension	1.14e-05	7.83e-05	CbGpPWpGaD
Cyclopentolate—CHRM3—Signaling by GPCR—PIK3R1—hypertension	1.14e-05	7.81e-05	CbGpPWpGaD
Cyclopentolate—CHRM3—Metabolism—PPARA—hypertension	1.13e-05	7.76e-05	CbGpPWpGaD
Cyclopentolate—CHRM1—Signaling Pathways—APOB—hypertension	1.12e-05	7.72e-05	CbGpPWpGaD
Cyclopentolate—CHRM3—Signaling Pathways—APOB—hypertension	1.12e-05	7.69e-05	CbGpPWpGaD
Cyclopentolate—CHRM1—Signaling Pathways—PTK2—hypertension	1.12e-05	7.69e-05	CbGpPWpGaD
Cyclopentolate—CHRM3—Signaling Pathways—PTK2—hypertension	1.11e-05	7.66e-05	CbGpPWpGaD
Cyclopentolate—CHRM1—GPCR downstream signaling—CXCL8—hypertension	1.11e-05	7.65e-05	CbGpPWpGaD
Cyclopentolate—CHRM3—GPCR downstream signaling—CXCL8—hypertension	1.11e-05	7.63e-05	CbGpPWpGaD
Cyclopentolate—CHRM1—Signaling Pathways—EDN1—hypertension	1.1e-05	7.6e-05	CbGpPWpGaD
Cyclopentolate—CHRM3—Signaling Pathways—EDN1—hypertension	1.1e-05	7.57e-05	CbGpPWpGaD
Cyclopentolate—CHRM1—Signaling Pathways—CCL5—hypertension	1.1e-05	7.54e-05	CbGpPWpGaD
Cyclopentolate—CHRM3—Metabolism—AGT—hypertension	1.09e-05	7.52e-05	CbGpPWpGaD
Cyclopentolate—CHRM3—Signaling Pathways—CCL5—hypertension	1.09e-05	7.51e-05	CbGpPWpGaD
Cyclopentolate—BCHE—Metabolism—ALB—hypertension	1.09e-05	7.5e-05	CbGpPWpGaD
Cyclopentolate—CHRM3—Metabolism—CALM1—hypertension	1.08e-05	7.39e-05	CbGpPWpGaD
Cyclopentolate—CHRM1—Signaling Pathways—LPL—hypertension	1.07e-05	7.37e-05	CbGpPWpGaD
Cyclopentolate—CHRM3—Metabolism—APOE—hypertension	1.07e-05	7.36e-05	CbGpPWpGaD
Cyclopentolate—CHRM3—Signaling Pathways—LPL—hypertension	1.07e-05	7.35e-05	CbGpPWpGaD
Cyclopentolate—CHRM1—Signaling Pathways—H2AFX—hypertension	1.06e-05	7.32e-05	CbGpPWpGaD
Cyclopentolate—CHRM1—Signaling Pathways—RPS6KB1—hypertension	1.06e-05	7.3e-05	CbGpPWpGaD
Cyclopentolate—CHRM1—Signaling Pathways—PDGFRB—hypertension	1.06e-05	7.3e-05	CbGpPWpGaD
Cyclopentolate—CHRM3—Metabolism—CAV1—hypertension	1.06e-05	7.3e-05	CbGpPWpGaD
Cyclopentolate—CHRM3—Signaling Pathways—H2AFX—hypertension	1.06e-05	7.29e-05	CbGpPWpGaD
Cyclopentolate—CHRM3—Signaling Pathways—PDGFRB—hypertension	1.06e-05	7.28e-05	CbGpPWpGaD
Cyclopentolate—CHRM3—Signaling Pathways—RPS6KB1—hypertension	1.06e-05	7.28e-05	CbGpPWpGaD
Cyclopentolate—CHRM3—Metabolism—APOA1—hypertension	1.06e-05	7.28e-05	CbGpPWpGaD
Cyclopentolate—CHRM1—Signaling Pathways—ADCY5—hypertension	1.05e-05	7.21e-05	CbGpPWpGaD
Cyclopentolate—CHRM3—Signaling Pathways—ADCY5—hypertension	1.05e-05	7.19e-05	CbGpPWpGaD
Cyclopentolate—BCHE—Metabolism—PIK3R1—hypertension	1.04e-05	7.17e-05	CbGpPWpGaD
Cyclopentolate—BCHE—Metabolism—NOS3—hypertension	1.04e-05	7.17e-05	CbGpPWpGaD
Cyclopentolate—CHRM1—Signaling Pathways—PRKCG—hypertension	1.04e-05	7.17e-05	CbGpPWpGaD
Cyclopentolate—CHRM3—Signaling Pathways—PRKCG—hypertension	1.04e-05	7.14e-05	CbGpPWpGaD
Cyclopentolate—CHRM1—Signaling Pathways—ITGB3—hypertension	1.04e-05	7.12e-05	CbGpPWpGaD
Cyclopentolate—CHRM1—Signaling Pathways—PRKCA—hypertension	1.04e-05	7.12e-05	CbGpPWpGaD
Cyclopentolate—CHRM3—Signaling Pathways—ITGB3—hypertension	1.03e-05	7.09e-05	CbGpPWpGaD
Cyclopentolate—CHRM3—Signaling Pathways—PRKCA—hypertension	1.03e-05	7.09e-05	CbGpPWpGaD
Cyclopentolate—CHRM1—Signaling Pathways—YWHAZ—hypertension	1.03e-05	7.06e-05	CbGpPWpGaD
Cyclopentolate—CHRM3—Signaling Pathways—YWHAZ—hypertension	1.02e-05	7.04e-05	CbGpPWpGaD
Cyclopentolate—CHRM1—Signaling Pathways—SPP1—hypertension	1.02e-05	6.98e-05	CbGpPWpGaD
Cyclopentolate—CHRM1—Signaling Pathways—NGF—hypertension	1.02e-05	6.98e-05	CbGpPWpGaD
Cyclopentolate—CHRM3—Signaling Pathways—NGF—hypertension	1.01e-05	6.96e-05	CbGpPWpGaD
Cyclopentolate—CHRM3—Signaling Pathways—SPP1—hypertension	1.01e-05	6.96e-05	CbGpPWpGaD
Cyclopentolate—CHRM1—Signaling by GPCR—CXCL8—hypertension	1.01e-05	6.95e-05	CbGpPWpGaD
Cyclopentolate—CHRM3—Signaling by GPCR—CXCL8—hypertension	1.01e-05	6.93e-05	CbGpPWpGaD
Cyclopentolate—CHRM1—Signaling Pathways—PRKCD—hypertension	9.88e-06	6.79e-05	CbGpPWpGaD
Cyclopentolate—CHRM1—Signaling Pathways—CCR5—hypertension	9.88e-06	6.79e-05	CbGpPWpGaD
Cyclopentolate—CHRM3—Signaling Pathways—CCR5—hypertension	9.85e-06	6.77e-05	CbGpPWpGaD
Cyclopentolate—CHRM3—Signaling Pathways—PRKCD—hypertension	9.85e-06	6.77e-05	CbGpPWpGaD
Cyclopentolate—CHRM1—Signaling Pathways—HTR2A—hypertension	9.67e-06	6.64e-05	CbGpPWpGaD
Cyclopentolate—CHRM1—Signaling Pathways—C3—hypertension	9.65e-06	6.64e-05	CbGpPWpGaD
Cyclopentolate—CHRM3—Signaling Pathways—HTR2A—hypertension	9.64e-06	6.62e-05	CbGpPWpGaD
Cyclopentolate—CHRM3—Signaling Pathways—C3—hypertension	9.62e-06	6.61e-05	CbGpPWpGaD
Cyclopentolate—BCHE—Metabolism—PTGS2—hypertension	9.55e-06	6.56e-05	CbGpPWpGaD
Cyclopentolate—CHRM1—Signaling Pathways—PDGFB—hypertension	9.4e-06	6.46e-05	CbGpPWpGaD
Cyclopentolate—CHRM3—Signaling Pathways—PDGFB—hypertension	9.37e-06	6.44e-05	CbGpPWpGaD
Cyclopentolate—CHRM1—Signaling Pathways—FGFR1—hypertension	9.35e-06	6.43e-05	CbGpPWpGaD
Cyclopentolate—CHRM3—Metabolism—PPARG—hypertension	9.33e-06	6.41e-05	CbGpPWpGaD
Cyclopentolate—CHRM3—Signaling Pathways—FGFR1—hypertension	9.32e-06	6.4e-05	CbGpPWpGaD
Cyclopentolate—CHRM1—Signaling Pathways—HIF1A—hypertension	9.21e-06	6.33e-05	CbGpPWpGaD
Cyclopentolate—CHRM3—Metabolism—POMC—hypertension	9.2e-06	6.33e-05	CbGpPWpGaD
Cyclopentolate—CHRM3—Signaling Pathways—HIF1A—hypertension	9.18e-06	6.31e-05	CbGpPWpGaD
Cyclopentolate—CHRM1—Signaling Pathways—AGT—hypertension	9.17e-06	6.3e-05	CbGpPWpGaD
Cyclopentolate—CHRM3—Metabolism—INS—hypertension	9.15e-06	6.29e-05	CbGpPWpGaD
Cyclopentolate—CHRM3—Signaling Pathways—AGT—hypertension	9.14e-06	6.28e-05	CbGpPWpGaD
Cyclopentolate—CHRM1—Signaling Pathways—CALM1—hypertension	9.02e-06	6.2e-05	CbGpPWpGaD
Cyclopentolate—CHRM3—Signaling Pathways—CALM1—hypertension	8.99e-06	6.18e-05	CbGpPWpGaD
Cyclopentolate—CHRM1—Signaling Pathways—APOE—hypertension	8.99e-06	6.18e-05	CbGpPWpGaD
Cyclopentolate—CHRM1—Signaling Pathways—LEP—hypertension	8.99e-06	6.18e-05	CbGpPWpGaD
Cyclopentolate—CHRM3—Signaling Pathways—APOE—hypertension	8.96e-06	6.16e-05	CbGpPWpGaD
Cyclopentolate—CHRM3—Signaling Pathways—LEP—hypertension	8.96e-06	6.16e-05	CbGpPWpGaD
Cyclopentolate—CHRM1—Signaling Pathways—CAV1—hypertension	8.9e-06	6.12e-05	CbGpPWpGaD
Cyclopentolate—CHRM1—Signaling Pathways—APOA1—hypertension	8.88e-06	6.11e-05	CbGpPWpGaD
Cyclopentolate—CHRM3—Signaling Pathways—CAV1—hypertension	8.88e-06	6.1e-05	CbGpPWpGaD
Cyclopentolate—CHRM3—Signaling Pathways—APOA1—hypertension	8.86e-06	6.09e-05	CbGpPWpGaD
Cyclopentolate—CHRM1—Signaling Pathways—KDR—hypertension	8.8e-06	6.05e-05	CbGpPWpGaD
Cyclopentolate—CHRM3—Signaling Pathways—KDR—hypertension	8.78e-06	6.03e-05	CbGpPWpGaD
Cyclopentolate—CHRM1—Signaling Pathways—PRKCB—hypertension	8.47e-06	5.83e-05	CbGpPWpGaD
Cyclopentolate—CHRM1—Signaling Pathways—F2—hypertension	8.47e-06	5.83e-05	CbGpPWpGaD
Cyclopentolate—CHRM1—Signaling Pathways—FN1—hypertension	8.47e-06	5.83e-05	CbGpPWpGaD
Cyclopentolate—CHRM3—Signaling Pathways—F2—hypertension	8.45e-06	5.81e-05	CbGpPWpGaD
Cyclopentolate—CHRM3—Signaling Pathways—PRKCB—hypertension	8.45e-06	5.81e-05	CbGpPWpGaD
Cyclopentolate—CHRM3—Signaling Pathways—FN1—hypertension	8.45e-06	5.81e-05	CbGpPWpGaD
Cyclopentolate—CHRM3—Metabolism—ALB—hypertension	8.39e-06	5.77e-05	CbGpPWpGaD
Cyclopentolate—BCHE—Metabolism—PTEN—hypertension	8.32e-06	5.72e-05	CbGpPWpGaD
Cyclopentolate—CHRM1—Signaling Pathways—NOTCH1—hypertension	8.29e-06	5.7e-05	CbGpPWpGaD
Cyclopentolate—CHRM3—Signaling Pathways—NOTCH1—hypertension	8.27e-06	5.68e-05	CbGpPWpGaD
Cyclopentolate—CHRM3—Metabolism—PIK3R1—hypertension	8.03e-06	5.52e-05	CbGpPWpGaD
Cyclopentolate—CHRM3—Metabolism—NOS3—hypertension	8.03e-06	5.52e-05	CbGpPWpGaD
Cyclopentolate—BCHE—Metabolism—EP300—hypertension	7.94e-06	5.46e-05	CbGpPWpGaD
Cyclopentolate—CHRM1—Signaling Pathways—POMC—hypertension	7.72e-06	5.31e-05	CbGpPWpGaD
Cyclopentolate—CHRM3—Signaling Pathways—POMC—hypertension	7.7e-06	5.29e-05	CbGpPWpGaD
Cyclopentolate—CHRM1—Signaling Pathways—INS—hypertension	7.68e-06	5.28e-05	CbGpPWpGaD
Cyclopentolate—CHRM3—Signaling Pathways—INS—hypertension	7.65e-06	5.26e-05	CbGpPWpGaD
Cyclopentolate—CHRM1—Signaling Pathways—CCL2—hypertension	7.55e-06	5.19e-05	CbGpPWpGaD
Cyclopentolate—CHRM3—Signaling Pathways—CCL2—hypertension	7.53e-06	5.18e-05	CbGpPWpGaD
Cyclopentolate—CHRM1—Signaling Pathways—IGF1—hypertension	7.43e-06	5.1e-05	CbGpPWpGaD
Cyclopentolate—CHRM1—Signaling Pathways—AKT2—hypertension	7.42e-06	5.1e-05	CbGpPWpGaD
Cyclopentolate—CHRM3—Signaling Pathways—IGF1—hypertension	7.4e-06	5.09e-05	CbGpPWpGaD
Cyclopentolate—CHRM3—Signaling Pathways—AKT2—hypertension	7.4e-06	5.08e-05	CbGpPWpGaD
Cyclopentolate—CHRM1—Signaling by GPCR—EGFR—hypertension	7.39e-06	5.08e-05	CbGpPWpGaD
Cyclopentolate—CHRM3—Signaling by GPCR—EGFR—hypertension	7.37e-06	5.06e-05	CbGpPWpGaD
Cyclopentolate—CHRM3—Metabolism—PTGS2—hypertension	7.34e-06	5.05e-05	CbGpPWpGaD
Cyclopentolate—CHRM1—Signaling Pathways—SERPINE1—hypertension	7.05e-06	4.85e-05	CbGpPWpGaD
Cyclopentolate—CHRM3—Signaling Pathways—SERPINE1—hypertension	7.03e-06	4.83e-05	CbGpPWpGaD
Cyclopentolate—CHRM1—Signaling Pathways—FGF2—hypertension	6.83e-06	4.69e-05	CbGpPWpGaD
Cyclopentolate—CHRM3—Signaling Pathways—FGF2—hypertension	6.8e-06	4.68e-05	CbGpPWpGaD
Cyclopentolate—CHRM1—Signaling Pathways—RHOA—hypertension	6.8e-06	4.68e-05	CbGpPWpGaD
Cyclopentolate—CHRM3—Signaling Pathways—RHOA—hypertension	6.78e-06	4.66e-05	CbGpPWpGaD
Cyclopentolate—CHRM1—Signaling Pathways—PIK3R1—hypertension	6.73e-06	4.63e-05	CbGpPWpGaD
Cyclopentolate—CHRM1—Signaling Pathways—NOS3—hypertension	6.73e-06	4.63e-05	CbGpPWpGaD
Cyclopentolate—CHRM3—Signaling Pathways—NOS3—hypertension	6.71e-06	4.61e-05	CbGpPWpGaD
Cyclopentolate—CHRM3—Signaling Pathways—PIK3R1—hypertension	6.71e-06	4.61e-05	CbGpPWpGaD
Cyclopentolate—CHRM3—Metabolism—PTEN—hypertension	6.4e-06	4.4e-05	CbGpPWpGaD
Cyclopentolate—CHRM1—Signaling Pathways—RELA—hypertension	6.34e-06	4.36e-05	CbGpPWpGaD
Cyclopentolate—CHRM3—Signaling Pathways—RELA—hypertension	6.32e-06	4.34e-05	CbGpPWpGaD
Cyclopentolate—CHRM1—Signaling Pathways—MTOR—hypertension	6.21e-06	4.27e-05	CbGpPWpGaD
Cyclopentolate—CHRM3—Signaling Pathways—MTOR—hypertension	6.19e-06	4.26e-05	CbGpPWpGaD
Cyclopentolate—CHRM3—Metabolism—EP300—hypertension	6.11e-06	4.2e-05	CbGpPWpGaD
Cyclopentolate—CHRM1—Signaling Pathways—CXCL8—hypertension	5.97e-06	4.11e-05	CbGpPWpGaD
Cyclopentolate—CHRM3—Signaling Pathways—CXCL8—hypertension	5.95e-06	4.09e-05	CbGpPWpGaD
Cyclopentolate—CHRM1—GPCR downstream signaling—AKT1—hypertension	5.77e-06	3.97e-05	CbGpPWpGaD
Cyclopentolate—CHRM3—GPCR downstream signaling—AKT1—hypertension	5.75e-06	3.95e-05	CbGpPWpGaD
Cyclopentolate—CHRM1—Signaling by GPCR—IL6—hypertension	5.68e-06	3.9e-05	CbGpPWpGaD
Cyclopentolate—CHRM3—Signaling by GPCR—IL6—hypertension	5.66e-06	3.89e-05	CbGpPWpGaD
Cyclopentolate—CHRM1—Signaling Pathways—MMP9—hypertension	5.4e-06	3.71e-05	CbGpPWpGaD
Cyclopentolate—CHRM3—Signaling Pathways—MMP9—hypertension	5.38e-06	3.7e-05	CbGpPWpGaD
Cyclopentolate—CHRM1—Signaling Pathways—CDKN1A—hypertension	5.38e-06	3.7e-05	CbGpPWpGaD
Cyclopentolate—CHRM1—Signaling Pathways—PTEN—hypertension	5.37e-06	3.69e-05	CbGpPWpGaD
Cyclopentolate—CHRM3—Signaling Pathways—CDKN1A—hypertension	5.36e-06	3.69e-05	CbGpPWpGaD
Cyclopentolate—CHRM3—Signaling Pathways—PTEN—hypertension	5.35e-06	3.68e-05	CbGpPWpGaD
Cyclopentolate—CHRM1—Signaling Pathways—MAPK8—hypertension	5.25e-06	3.61e-05	CbGpPWpGaD
Cyclopentolate—CHRM1—Signaling by GPCR—AKT1—hypertension	5.24e-06	3.6e-05	CbGpPWpGaD
Cyclopentolate—CHRM3—Signaling Pathways—MAPK8—hypertension	5.24e-06	3.6e-05	CbGpPWpGaD
Cyclopentolate—CHRM3—Signaling by GPCR—AKT1—hypertension	5.22e-06	3.59e-05	CbGpPWpGaD
Cyclopentolate—CHRM1—Signaling Pathways—EP300—hypertension	5.12e-06	3.52e-05	CbGpPWpGaD
Cyclopentolate—CHRM3—Signaling Pathways—EP300—hypertension	5.1e-06	3.51e-05	CbGpPWpGaD
Cyclopentolate—CHRM1—Signaling Pathways—SRC—hypertension	4.98e-06	3.42e-05	CbGpPWpGaD
Cyclopentolate—CHRM3—Signaling Pathways—SRC—hypertension	4.96e-06	3.41e-05	CbGpPWpGaD
Cyclopentolate—CHRM1—Signaling Pathways—VEGFA—hypertension	4.85e-06	3.33e-05	CbGpPWpGaD
Cyclopentolate—CHRM3—Signaling Pathways—VEGFA—hypertension	4.83e-06	3.32e-05	CbGpPWpGaD
Cyclopentolate—BCHE—Metabolism—AKT1—hypertension	4.8e-06	3.3e-05	CbGpPWpGaD
Cyclopentolate—CHRM1—Signaling Pathways—MYC—hypertension	4.46e-06	3.07e-05	CbGpPWpGaD
Cyclopentolate—CHRM1—Signaling Pathways—TGFB1—hypertension	4.45e-06	3.06e-05	CbGpPWpGaD
Cyclopentolate—CHRM3—Signaling Pathways—MYC—hypertension	4.45e-06	3.06e-05	CbGpPWpGaD
Cyclopentolate—CHRM3—Signaling Pathways—TGFB1—hypertension	4.44e-06	3.05e-05	CbGpPWpGaD
Cyclopentolate—CHRM1—Signaling Pathways—EGFR—hypertension	4.36e-06	3e-05	CbGpPWpGaD
Cyclopentolate—CHRM3—Signaling Pathways—EGFR—hypertension	4.35e-06	2.99e-05	CbGpPWpGaD
Cyclopentolate—CHRM3—Metabolism—AKT1—hypertension	3.69e-06	2.54e-05	CbGpPWpGaD
Cyclopentolate—CHRM1—Signaling Pathways—TP53—hypertension	3.66e-06	2.52e-05	CbGpPWpGaD
Cyclopentolate—CHRM3—Signaling Pathways—TP53—hypertension	3.65e-06	2.51e-05	CbGpPWpGaD
Cyclopentolate—CHRM1—Signaling Pathways—IL6—hypertension	3.35e-06	2.31e-05	CbGpPWpGaD
Cyclopentolate—CHRM3—Signaling Pathways—IL6—hypertension	3.34e-06	2.3e-05	CbGpPWpGaD
Cyclopentolate—CHRM1—Signaling Pathways—AKT1—hypertension	3.09e-06	2.13e-05	CbGpPWpGaD
Cyclopentolate—CHRM3—Signaling Pathways—AKT1—hypertension	3.08e-06	2.12e-05	CbGpPWpGaD
